AI assistant
Sending…
RESMED INC — Director's Dealing 2012
Mar 20, 2012
30071_dirs_2012-03-20_5808e3c7-d0d0-4559-a059-b2bb1896ed22.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2012-03-12
Reporting Person: Relser Anne (President - ResMed Europe)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 3148.705 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-Qualified Stock Options | $20.3550 | 2016-02-23 | ResMed Common Stock (6400) | Direct | |
| Non-Qualified Stock Options | $24.57 | 2013-11-24 | ResMed Common Stock (10000) | Direct | |
| Non-Qualified Stock Options | $22.535 | 2014-11-27 | ResMed Common Stock (30000) | Direct | |
| Non-Qualified Stock Options | $20.80 | 2015-02-26 | ResMed Common Stock (10000) | Direct | |
| Non-Qualified Stock Options | $17.30 | 2015-11-24 | ResMed Common Stock (34000) | Direct | |
| Restricted Stock Units | $0 | ResMed Common Stock (10286) | Direct | ||
| Restricted Stock Units | $0 | ResMed Common Stock (5429) | Direct | ||
| Restricted Stock Units | $0 | ResMed Common Stock (5429) | Direct |
Footnotes
F1: Restricted Stock Units do not have an expiration date.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29